Coffee and the caffeine in it were long-considered a risk for patients with certain heart conditions. But a recent study changed the thinking on that.
Doctors typically recommend that people with heart issues like A-Fib avoid caffeine out of fear that it will trigger symptoms. But a study by UC San Francisco and the University of Adelaide concluded ...
After claiming its approval in Europe earlier this year, Abbott has secured the FDA’s go-ahead for its Volt pulsed field ablation system for irregular heart rhythms, a step forward in an | With the U.
A routine blood test identified abnormalities, leading to follow-up tests. A hematologist diagnosed Evans with early-stage ...
Edgewise Therapeutics (EWTX) announced positive updates from the ongoing CIRRUS-HCM, Phase 2 clinical trial of EDG-7500, a novel oral, selective, ...
Background The growing population of patients with adult congenital heart disease (ACHD) present complex lifelong care needs ...
Edgewise Therapeutics, Inc., (Nasdaq: EWTX), today announced positive updates from the ongoing CIRRUS-HCM, Phase 2 clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback